Can CBD work as a new kind of antipsychotic?
Emerging evidence from preclinical, experimental, neuroimaging, and clinical studies suggests CBD has antipsychotic properties through mechanisms distinct from current medications.
Quick Facts
What This Study Found
CBD shows potential as a novel antipsychotic with a unique non-dopamine-D2 mechanism of action. Clinical evidence suggests possible benefits for positive, negative, and cognitive symptoms of psychosis, with a favorable safety and tolerability profile.
Key Numbers
Psychotic disorders like schizophrenia contribute substantially to the global burden of disease. D2 antagonists have been the mainstay since the 1950s, but a significant proportion of patients don't achieve adequate remission.
How They Did This
Narrative review synthesizing preclinical studies, human experimental and neuroimaging research, and clinical trials evaluating CBD's antipsychotic effects, safety, tolerability, and potential mechanisms.
Why This Research Matters
Current antipsychotics all work by blocking dopamine D2 receptors, causing significant side effects. A substantial number of patients don't respond adequately. CBD represents a fundamentally different pharmacological approach that could help treatment-resistant patients.
The Bigger Picture
If CBD proves effective as an antipsychotic, it would be the first new class of antipsychotic medication with a non-D2 mechanism in decades. This could transform treatment options for the millions of people living with psychotic disorders worldwide.
What This Study Doesn't Tell Us
This is a narrative review, not a systematic review or meta-analysis. The clinical evidence base for CBD as an antipsychotic is still limited, with few large-scale randomized controlled trials completed.
Questions This Raises
- ?What is the optimal dose of CBD for antipsychotic effects?
- ?Can CBD be combined with traditional antipsychotics for enhanced benefit?
- ?Which specific patient populations would benefit most?
Trust & Context
- Key Stat:
- CBD operates through a non-D2 mechanism unlike all current antipsychotics
- Evidence Grade:
- Moderate: review synthesizes multiple lines of evidence including some clinical trials, but large-scale RCTs are limited.
- Study Age:
- Published in 2019.
- Original Title:
- Cannabidiol as a potential treatment for psychosis.
- Published In:
- Therapeutic advances in psychopharmacology, 9, 2045125319881916 (2019)
- Authors:
- Davies, Cathy(3), Bhattacharyya, Sagnik(39)
- Database ID:
- RTHC-02000
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Is CBD approved as an antipsychotic?
No. While research shows promise, CBD is not approved for treating psychosis. The evidence reviewed here is primarily from early-stage clinical trials and preclinical research.
How is CBD different from current antipsychotics?
All current antipsychotics work by blocking dopamine D2 receptors. CBD appears to work through entirely different mechanisms, which could mean fewer of the movement-related and metabolic side effects associated with D2 blockers.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02000APA
Davies, Cathy; Bhattacharyya, Sagnik. (2019). Cannabidiol as a potential treatment for psychosis.. Therapeutic advances in psychopharmacology, 9, 2045125319881916. https://doi.org/10.1177/2045125319881916
MLA
Davies, Cathy, et al. "Cannabidiol as a potential treatment for psychosis.." Therapeutic advances in psychopharmacology, 2019. https://doi.org/10.1177/2045125319881916
RethinkTHC
RethinkTHC Research Database. "Cannabidiol as a potential treatment for psychosis." RTHC-02000. Retrieved from https://rethinkthc.com/research/davies-2019-cannabidiol-as-a-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.